Globus Medical (MEX:GMED) Moat Score: 5/10 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GMED Globus Medical Inc MEX:GMED
90 GF Score
Price MXN1,390.45
GF Value MXN1,783.75
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Moat Score?

Globus Medical MEX:GMED 90 Moat Score is 5 as of Jul. 18, 2026. GuruFocus rates MEX:GMED with a GF Score™ of 90/100 and a GF Value™ of MXN1,783.75 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 842 Medical Devices & Instruments companies, Globus Medical ranks better than 91.21% on this metric.

Globus Medical has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Globus Medical has Narrow Moat: Globus Medical Inc has a solid narrow moat with strong R&D capabilities and valuable intellectual property in the medical device industry. However, it faces competition and lacks significant regulatory barriers or exclusive licenses.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Globus Medical might have Narrow Moat - Solid narrow moat.

Globus Medical  (MEX:GMED) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Globus Medical Moat Score Related Terms

MEX:GMED vs PEN, PODD, BRKR: Moat Score Comparison

For the Medical Devices subindustry, Globus Medical's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Globus Medical Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Moat Score distribution charts can be found below:

* The bar in red indicates where Globus Medical's Moat Score falls into.


MEX:GMED
90GF Score
Globus Medical Inc MEX:GMED
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Globus Medical (MEX:GMED) has a Moat Score of 5 as of Jul. 18, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Globus Medical ranks #74 out of 842 companies in the Medical Devices & Instruments industry, placing it in the top 8.8%.
Is Globus Medical's Moat Score too high?
Globus Medical's current Moat Score is 5. Based on the distribution chart, Globus Medical ranks #74 out of 842 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Moat Score compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #74 out of 842 companies for Moat Score. This places Globus Medical in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Globus Medical's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,783.75, compared to a current price of MXN1,390.45 — trading 22% below its estimated fair value. The current Moat Score is 5. Globus Medical's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Moat Score is 5 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (MEX:GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of MXN1,390.45 is trading 22% below its estimated GF Value™ of MXN1,783.75. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for MEX:GMED:

  • Moat Score: 5
  • GF Value™: MXN1,783.75 vs. price of MXN1,390.45 (22% below fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globus Medical Business Description

Other Exchanges GMED:USAGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
90GF Score

Get the complete analysis for MEX:GMED

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,390.45
Price
MXN1,783.75
GF Value